Advertisement

Picture EBD Group BIO-Europe 2023 Munich BEU23 650x100px
Document › Details

Wilex AG. (4/24/17). "Press Release: Wilex AG Plans Rights Issue Using Authorised Capital. Ad-hoc release [Not for distribution, publication or transmission in the USA, Canada, Japan and Australia]". Munich.

Organisations Organisation Wilex AG
  Today Heidelberg Pharma AG (FSE: HPHA)
  Group Heidelberg Pharma (Group)
  Organisation 2 Dievini Hopp BioTech Holding GmbH & Co. KG
  Group HOPP Group (family of Dietmar Hopp)
Products Product Antibody Targeted Amanitin Conjugate (ATAC)
  Product 2 investment banking
Persons Person Wimmer, Sylvia (Heidelberg Pharma 202203 Corporate Communciations formerly Wilex 201403 Corporate Communications)
  Person 2 Arnold, Katja (MC Services 201309 CIRO Executive Director before Wilex AG + CAT Consultants)
     


   
Record changed: 2023-06-05

Advertisement

Picture EBD Group BIO-Europe 2023 Munich BEU23 650x200px

More documents for Heidelberg Pharma (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x300px




» top